Application Areas
Type 2 Diabetes Management: Treatment of adult patients with poor glycemic control using monotherapy or in combination with metformin/sulfonylureas; HbA1c levels can be reduced by up to 1.14%.
Cardiovascular Risk Reduction: Reduces the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adult patients with type 2 diabetes and cardiovascular disease.
Chronic Weight Management: Long-term weight management in adults and adolescents aged 12 years and older with obesity (BMI ≥30 kg/m² or ≥27 kg/m² with comorbidities), with an average weight loss of 5–10%.
Metabolic Syndrome Intervention: Adjunctive management of metabolic abnormalities such as hyperinsulinemia, insulin resistance, and non-alcoholic fatty liver disease (NAFLD).
Research and Formulation Development: GLP-1 receptor mechanism research, development of novel drug delivery systems (oral formulations, sustained-release microspheres, transdermal patches, etc.), and biosimilar development.
Why Choose Us?
As the source production plant for liraglutide peptides, we possess the following core advantages:
1. Source Plant, Controllable Costs: We have a complete peptide production line equipped with precision instruments such as Waters LC-MS/MS, Waters UPLC, fully automated purification systems, and freeze-drying systems. We have complete control over the entire process from raw material procurement to finished product delivery, eliminating intermediate links and providing customers with high-performance, cost-effective products. Liraglutide synthesis can be achieved using solid-phase fragment condensation (CSPPS), a convergent synthesis strategy that breaks down long peptide chains into multiple short fragments, prepares them separately, and then conjugates them sequentially, effectively reducing synthesis difficulty and cost.
2. Professional Production Equipment and Technology: Our R&D center is equipped with a sterile laboratory and multiple peptide production lines, accumulating rich experience in peptide synthesis. The company has obtained multiple utility model patents and invention patents. For the synthesis of long-chain peptides (>30 amino acid residues) like liraglutide, we continuously follow up on advanced process optimization, including emerging technologies such as resin-sewn solid-phase extension strategies, to further improve crude peptide purity and recovery rate.
3. Stable Supply: Leveraging large-scale production capacity and a mature production management system, we can guarantee a continuous and stable supply of bulk orders, meeting diverse customer needs from milligram to kilogram levels.
4. Stable Quality: A strict quality control system has been established. Products undergo double HPLC testing before leaving the warehouse, achieving a purity of over 98% and single impurities controlled below 1%. We support third-party testing and verification by customers to ensure the reliability of each batch and consistency between batches.
Storage and Usage Methods
1. Storage Conditions
Unopened Lyophilized Powder: Sealed, protected from light and moisture; long-term storage at -20℃ (recommended), short-term storage at 2–8℃ ≤1 month; shelf life 24 months.
Opened: Store in a desiccator/nitrogen-filled container, avoid repeated exposure to room temperature, repackaging is recommended.
Reconstituted Solution: Store at 2–8℃, recommended for use within 28 days; do not freeze-thaw; avoid repeated freeze-thaw cycles.
Contraindications: Do not freeze, do not expose to high temperatures (>30℃ accelerates aggregation), and do not expose to direct light.
2. Reconstitution Recommendations (Research-grade Lyophilized Powder)
Slowly pour the solution along the bottle wall using sterile water/antibacterial aqueous solution (BAC) containing 0.9% benzyl alcohol/dilute acetic acid (pH 7–8 buffer system), gently swirl (do not shake violently), and let stand at room temperature for 5–10 min until clear and colorless.
Due to the hydrophobic nature of the C16 side chain, its solubility is lower than that of short peptides; for higher concentrations, it can be diluted with a small amount of DMSO (<10%) before dilution, or a pH 8.0 phosphate buffer solution can be used.
Discard any solution that is cloudy, discolored, or contains particles.
3. Formulation/Experimental Tips
Research dosage is based on clinical dosage of 0.6–3.0 mg/day (human) converted to animal dosage; it is strictly forbidden to directly claim that the raw material powder is suitable for human injection.
It is not suitable for coexistence with strong acids (pH<4), high-temperature shearing, or strong oxidizing agents.
FAQ
Q: Where is your product manufactured?
A: Our products are from Shenzhen, China.
Q: What is the minimum order quantity?
A: The minimum order quantity is 10 bottles/set.
Q: How long does it take to ship?
A: In-stock orders will be shipped within 24 hours.
Q: What purity level can you provide?
A: Standard purity 99%.
Q: Which courier service do you use?
A: FedEx, DHL, UPS, and postal services are available.
Q: How long does shipping take?
A: Approximately 10-15 days.
Q: Can you provide a COA (Certificate of Authorization) quality inspection report and HPLC (High-Performance Computational) report?
A: Yes, all goods undergo professional testing before shipment.
Q: Do you support OEM branding?
A: OEM branding service is supported, subject to the minimum order quantity requirement.
Q: What are your after-sales service details? A: After the customer signs for the goods, if the quality problem is confirmed to be caused by our production, they can enjoy free replacement or refund. We adhere to the service principle of pragmatism and responsibility, actively respond to and properly handle all kinds of issues, without shirking responsibility or avoiding problems, and do our best to protect the rights and interests of our customers.
Q: What payment methods are available?
A: We support bank transfer, Bitcoin, Transferwise, and Xoom.
Hot Tags: liraglutide 5mg/vial is used for cardiovascular and renal protection. cas: 204656-20-2, China liraglutide 5mg/vial is used for cardiovascular and renal protection. cas: 204656-20-2 manufacturers, suppliers, factory
